» Authors » Wei-Chieh Huang

Wei-Chieh Huang

Explore the profile of Wei-Chieh Huang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 92
Citations 883
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Lin C, Chiang C, Shih Y, Tung S, Huang W
Anticancer Res . 2024 May; 44(6):2517-2531. PMID: 38821588
Background/aim: Despite advances in oral squamous cell carcinoma (OSCC) diagnosis and treatment, the five-year survival rate remains low, underscoring the need for improved biomarkers and therapeutic strategies. This study investigated...
12.
Lee D, Huang W, Wu C, Yang C
ESC Heart Fail . 2024 Feb; 11(3):1810-1811. PMID: 38424001
No abstract available.
13.
Huang W, Shu L, Kuo Y, Lai K, Hsia C, Yen T, et al.
Int J Mol Sci . 2024 Feb; 25(4). PMID: 38396774
Platelets assume a pivotal role in the pathogenesis of cardiovascular diseases (CVDs), emphasizing their significance in disease progression. Consequently, addressing CVDs necessitates a targeted approach focused on mitigating platelet activation....
14.
Kao T, Liao C, Tsai C, Chang Y, Pan C, Chang C, et al.
Ther Adv Chronic Dis . 2024 Feb; 14:20406223231210114. PMID: 38362007
Background: Primary aldosteronism (PA) has been associated with atherosclerosis beyond the extent of essential hypertension, but the impact of albuminuria remains unknown. Objective: To investigate the effect of concomitant albuminuria...
15.
Hsia C, Shu L, Lee A, Tran O, Yang C, Yen T, et al.
J Cell Mol Med . 2024 Feb; 28(4):e18139. PMID: 38334198
Platelets assume a pivotal role in the cardiovascular diseases (CVDs). Thus, targeting platelet activation is imperative for mitigating CVDs. Ginkgetin (GK), from Ginkgo biloba L, renowned for its anticancer and...
16.
Chen Z, Liao C, Pan C, Tsai C, Chang Y, Chang C, et al.
J Hypertens . 2023 Dec; 42(3):538-545. PMID: 38088428
Objective: Hyperaldosteronism has adverse effects on cardiovascular structure and function. Laparoscopic adrenalectomy is the gold standard for patients with unilateral primary aldosteronism. For unilateral primary aldosteronism patients unable or unwilling...
17.
Chen L, Hung K, Tseng Y, Wang H, Lu T, Huang W, et al.
IEEE J Transl Eng Health Med . 2023 Dec; 12:43-55. PMID: 38059127
Objective: Leveraging patient data through machine learning techniques in disease care offers a multitude of substantial benefits. Nonetheless, the inherent nature of patient data poses several challenges. Prevalent cases amass...
18.
Lee D, Chen T, Huang W, Chou R, Wu C, Yang C, et al.
ESC Heart Fail . 2023 Oct; 11(1):189-197. PMID: 37885349
Aims: Patients with high-flow arteriovenous (AV) access are at risk of developing high-output cardiac failure (HOCF) and subsequent hospitalization. However, diagnosing HOCF is challenging and often requires invasive procedures. The...
19.
Chang Y, Hsia C, Huang W, Jayakumar T, Hsia C, Yen T, et al.
Heliyon . 2023 Sep; 9(10):e20286. PMID: 37767484
Platelets play a vital role in the formation of dangerous arterial thrombosis. Platelets are activated by adhesive proteins or soluble agonists through their specific receptors. The receptor-mediated signaling pathways lead...
20.
Huang W, Liu F, Cheng H, Tsai Y, Huang Y, Lai T, et al.
J Formos Med Assoc . 2023 Aug; 123 Suppl 2:S82-S90. PMID: 37633770
The prevalence of patients with primary aldosteronism (PA) is about 5%-15% in hypertensive patients, and it is common cause of secondary hypertension in clinical practice. Two major causes of PA...